Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
01 mai 2018 07h35 HE
|
Endonovo Therapeutics, Inc.
Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics,...
Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
12 févr. 2018 09h32 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™...
Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema
22 janv. 2018 07h00 HE
|
Endonovo Therapeutics, Inc.
Seeking Distribution Partners in Europe for CE-Marked Electroceutical™ Device for Promotion of Wound Healing, Reduction of Pain and Post-Operative Edema LOS ANGELES, CA, Jan. 22, 2018 (GLOBE...
Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
28 déc. 2017 09h30 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...
Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
26 déc. 2017 07h30 HE
|
Endonovo Therapeutics, Inc.
Endonovo to Fund All Currently Planned and Future Clinical Trials for Traumatic Brain Injury, Post-Concussion Syndrome, Stroke and Other Central Nervous System Disorders LOS ANGELES, CA, Dec. ...